Immunocore Holdings's market cap is currently $1.49B. The company's EPS TTM is $-0.956; its P/E ratio is ―; Immunocore Holdings is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 249.43M	$ 143.74M	$ 26.52M	$ 30.11M	$ 25.67M
Gross Profit	$ 248.39M	$ 143.28M	$ -46.71M	$ -44.70M	$ -74.32M
Operating Income	$ -59.65M	$ -39.61M	$ -135.16M	$ -86.19M	$ -118.32M
EBITDA	$ -51.65M	$ -38.35M	$ -166.72M	-	$ -113.18M
Net Income	$ -55.29M	$ -41.22M	$ -131.52M	$ -74.09M	$ -103.93M
Balance Sheet
Cash & Short-Term Investments	$ 442.63M	$ 332.54M	$ 237.89M	$ 129.72M	$ 73.97M
Total Assets	$ 597.00M	$ 435.52M	$ 301.77M	$ 197.19M	$ 185.65M
Total Debt	$ 84.03M	$ 69.30M	$ 63.84M	$ 63.89M	$ 59.41M
Net Debt	$ -358.59M	$ -263.24M	$ -174.05M	$ -65.83M	$ -14.56M
Total Liabilities	$ 228.16M	$ 156.76M	$ 130.23M	$ 141.85M	$ 170.88M
Stockholders' Equity	$ 368.84M	$ 278.76M	$ 171.55M	$ 55.35M	$ 14.77M
Cash Flow
Free Cash Flow	$ -2.48M	$ -33.47M	$ -130.76M	$ -63.65M	$ -105.65M
Operating Cash Flow	$ 2.94M	$ -31.27M	$ -129.75M	$ -60.57M	$ -101.38M
Investing Cash Flow	$ -5.42M	$ 233.00K	$ -495.00K	$ 467.00K	$ -4.14M
Financing Cash Flow	$ 34.35M	$ 138.23M	$ 276.25M	$ 115.94M	$ 55.13M

Currency in USD

Immunocore Holdings Earnings and Revenue History

Income Statement >

Immunocore Holdings Debt to Assets

Balance Sheet >

Immunocore Holdings Cash Flow

Cash Flow >

Immunocore Holdings Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing